FDA Approves Aimovig to Prevent Migraines
Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo
Social, Communication Delays With False-Negative on M-CHAT
Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD
Various Clinical Disturbances Precede MS Diagnosis
Understanding prodromal signs may improve multiple sclerosis identification
Language Used in Medical Record Can Affect Patient Care
Stigmatizing language may transmit bias, influence trainees' attitudes
Seafood Recommended 1 to 2 Times/Week for Cardiac Benefit
Benefits of seafood consumption include reduced risk of cardiac death, coronary heart disease, stroke
Aerobic + Strength Exercise Doesn’t Slow Cognitive Decline
Moderate-to-high intensity exercise ups physical fitness but does not slow cognitive decline in dementia
Best Practices Developed for Use of EHR to Enhance Patient Care
Patients regard EHR as positive presence; can be used to engage patients by jointly viewing data
Fremanezumab Linked to Fewer Monthly Migraine Days
For episodic migraine patients, reduction in number of migraine days with monthly dosing, single dose
Disruption of Circadian Rhythm Negatively Impacts Mental Health
Reduction in relative amplitude tied to higher risk of lifetime major depressive disorder, bipolar disorder
Better Diet Quality Associated With Larger Brain Volume
Relationship seen with gray matter, white matter, and hippocampal volumes
